Old Web
English
Sign In
Acemap
>
Paper
>
Sweet Syndrome Successfully Treated with Ruxolitinib in JAK-2 Positive Myeloproliferative Disorder
Sweet Syndrome Successfully Treated with Ruxolitinib in JAK-2 Positive Myeloproliferative Disorder
2018
S. Melboucy-Belkhir
F. Brigant
R. Khentache
Bouketouche M
R. Garidi
B. Brihaye
Keywords:
Sweet Syndrome
Janus kinase 2
Oncology
Ruxolitinib
Internal medicine
Medicine
Correction
Source
Cite
Save
Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI
[]